Written question asked by Kerry McCarthy (Labour) on Tuesday, 7 September 2021, in the House of Commons. It was due for an answer on Friday, 10 September 2021 (named day). It was answered by Edward Argar (Conservative) on Friday, 1 October 2021 on behalf of the Department of Health and Social Care.
ME/CFS: Health Services
- Question
-
To ask the Secretary of State for Health and Social Care, what support his Department is providing to people with myalgic encephomyelitis and chronic fatigue syndrome pending the publication of updated clinical guidelines for that condition.
- Answer
-
The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for developing its guidelines in line with its established methods and processes. NICE the Department regarding its publication of an updated guideline on chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). NICE now plans to host a roundtable event in October to determine how it can gain support for the guideline to ensure effective implementation.
Services for CFS/ME are commissioned locally by clinical commissioning groups to plan the provision of services subject to local prioritisation and funding. NICE’s existing guideline on CFS/ME provides guidance on diagnosing and managing the condition. Health and care professionals should continue to take this into account until the updated guideline is published.
Secondary information
- Type
- Written question
- Reference
- 44241
- Session
- 2021-22
- Grouped for answer
- Yes
- Subjects
- ME/CFS Health services National Institute for Health and Care Excellence
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-05-07 08:31:57 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/44241
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/44241
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/44241